Circulation, Vol 74, 758-765, Copyright © 1986 by American Heart Association
GH Dahlen, JR Guyton, M Attar, JA Farmer, JA Kautz and AM Gotto Jr
In a study of 307 white patients who underwent coronary angiography, the
relationship of coronary artery disease (CAD) to plasma levels of
lipoprotein Lp(a) and other lipid-lipoprotein variables was examined. Lp(a)
resembles low-density lipoprotein (LDL) in several ways, but can be
distinguished and quantified by electroimmunoassay. CAD was rated as
present or absent and was also represented by a quantitative lesion score
derived from estimates of stenosis in four major coronary vessels. Coronary
lesion scores significantly correlated with Lp(a), total cholesterol,
triglycerides, LDL cholesterol, and high-density lipoprotein (HDL)
cholesterol levels by univariate statistical analysis. By multivariate
analysis levels of Lp(a) were associated significantly and independently
with the presence of CAD (p less than .02), and tended to correlate with
lesion scores (p = .06). Among subgroups Lp(a) level was associated with
CAD in women of all ages and in men 55 years old or younger. An apparent
threshold for coronary risk occurred at Lp(a) lipoprotein mass
concentrations of 30 to 40 mg/dl, corresponding to Lp(a) cholesterol
concentrations of approximately 10 to 13 mg/dl. Plasma Lp(a) in white
patients appears to be a major coronary risk factor with an importance
approaching that of the level of LDL or HDL cholesterol.
ARTICLES
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography
This article has been cited by other articles:
 |
|
 |
|
  The Emerging Risk Factors Collaboration Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality JAMA, July 22, 2009; 302(4): 412 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Derby, S. L. Crawford, R. C. Pasternak, M. Sowers, B. Sternfeld, and K. A. Matthews Lipid Changes During the Menopause Transition in Relation to Age and Weight: The Study of Women's Health Across the Nation Am. J. Epidemiol., June 1, 2009; 169(11): 1352 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Mallika, B. Goswami, and M. Rajappa Atherosclerosis Pathophysiology and the Role of Novel Risk Factors: A Clinicobiochemical Perspective Angiology, November 1, 2007; 58(5): 513 - 522. [Abstract] [PDF]
|
|
|
|
 |
|
 A N Kiani, E K Fishman, and M Petri Aortic valve calcification in systemic lupus erythematosus Lupus, December 1, 2006; 15(12): 873 - 876. [Abstract] [PDF]
|
|
|
|
|
|
J. Suk Danik, N. Rifai, J. E. Buring, and P. M Ridker Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. JAMA, September 20, 2006; 296(11): 1363 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rubin, H. J. Kim, T. A. Pearson, S. Holleran, R. Ramakrishnan, and L. Berglund Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a] J. Lipid Res., May 1, 2006; 47(5): 982 - 989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tsimikas, E. S. Brilakis, E. R. Miller, J. P. McConnell, R. J. Lennon, K. S. Kornman, J. L. Witztum, and P. B. Berger Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease N. Engl. J. Med., July 7, 2005; 353(1): 46 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ohtake, S. Kobayashi, H. Moriya, K. Negishi, K. Okamoto, K. Maesato, and S. Saito High Prevalence of Occult Coronary Artery Stenosis in Patients with Chronic Kidney Disease at the Initiation of Renal Replacement Therapy: An Angiographic Examination J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1141 - 1148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Sharp, M. A. Perugini, S. M. Marcovina, and S. P. A. McCormick Structural features of apolipoprotein B synthetic peptides that inhibit lipoprotein(a) assembly J. Lipid Res., December 1, 2004; 45(12): 2227 - 2234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Berglund and R. Ramakrishnan Lipoprotein(a): An Elusive Cardiovascular Risk Factor Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2219 - 2226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. J. Kullo, K. R. Bailey, L. F. Bielak, P. F. Sheedy II, G. G. Klee, S. L. Kardia, P. A. Peyser, E. Boerwinkle, and S. T. Turner Lack of Association Between Lipoprotein(a) and Coronary Artery Calcification in the Genetic Epidemiology Network of Arteriopathy (GENOA) Study Mayo Clin. Proc., October 1, 2004; 79(10): 1258 - 1263. [Abstract] [PDF]
|
|
|
|
|
|
T. Uchida, T. Inoue, H. Kamishirado, K. Takayanagi, and S. Morooka Prediction of Short-Term Progression or Regression of Atherosclerotic Coronary Artery Disease by Lipoprotein (a): A Quantitative Coronary Angiographic Study Angiology, November 1, 2003; 54(6): 641 - 646. [Abstract] [PDF]
|
|
|
|
 |
|
 C.A Glader, L.S Birgander, S Soderberg, H.P Ildgruben, P Saikku, A Waldenstrom, and G.H Dahlen Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis Eur. Heart J., January 2, 2003; 24(2): 198 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rubin, F. Paultre, C. H. Tuck, S. Holleran, R. G. Reed, T. A. Pearson, C. M. Thomas, R. Ramakrishnan, and L. Berglund Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians J. Lipid Res., February 1, 2002; 43(2): 234 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Caplice, C. Panetta, T. E. Peterson, L. S. Kleppe, C. S. Mueske, G. M. Kostner, G. J. Broze Jr, and R. D. Simari Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis Blood, November 15, 2001; 98(10): 2980 - 2987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rubin, T. A. Pearson, R. G. Reed, and L. Berglund Fluorescence-based, Nonradioactive Method for Efficient Detection of the Pentanucleotide Repeat (TTTTA)n Polymorphism in the Apolipoprotein(a) Gene Clin. Chem., October 1, 2001; 47(10): 1758 - 1762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sarti, L. Pantoni, G. Pracucci, A. Di Carlo, P. Vanni, and D. Inzitari Lipoprotein(a) and Cognitive Performances in an Elderly White Population : Cross-Sectional and Follow-Up Data Stroke, July 1, 2001; 32(7): 1678 - 1683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P A Gordon, J George, M A Khamashta, D Harats, G Hughes, and Y Shoenfeld Atherosclerosis and autoimmunity Lupus, April 1, 2001; 10(4): 249 - 252. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Ricci, G. Tamaro, R. Simeone, E. Giolo, G. Nucera, F. De Seta, and S. Guaschino Lipoprotein(a) changes during natural menstrual cycle and ovarian stimulation with recombinant and highly purified urinary FSH Hum. Reprod., March 1, 2001; 16(3): 449 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Goldstein, R. Adams, K. Becker, C. D. Furberg, P. B. Gorelick, G. Hademenos, M. Hill, G. Howard, V. J. Howard, B. Jacobs, et al. Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association Circulation, January 2, 2001; 103(1): 163 - 182. [Full Text] [PDF]
|
|
|
|
|
|
L. B. Goldstein, R. Adams, K. Becker, C. D. Furberg, P. B. Gorelick, G. Hademenos, M. Hill, G. Howard, V. J. Howard, B. Jacobs, et al. Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association Stroke, January 1, 2001; 32(1): 280 - 299. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Seed, R. H Sands, M. McLaren, G. Kirk, and D. Darko The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women Fam. Pract., December 1, 2000; 17(6): 497 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.A Glader, J Boman, P Saikku, H Stenlund, L Weinehall, G Hallmanns, and G.H Dahlen The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae -specific IgG antibodies Eur. Heart J., April 2, 2000; 21(8): 639 - 646. [Abstract] [PDF]
|
|
|
|
|
|
F I Romero, M A Khamashta, and G R. Hughes Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis Lupus, March 1, 2000; 9(3): 206 - 209. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Nishino, M. J. Malloy, J. Naya-Vigne, J. Russell, J. P. Kane, and R. F. Redberg Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women J. Am. Coll. Cardiol., February 1, 2000; 35(2): 314 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Foody, J. A. Milberg, K. Robinson, G. L. Pearce, D. W. Jacobsen, and D. L. Sprecher Homocysteine and Lipoprotein(a) Interact to Increase CAD Risk in Young Men and Women Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 493 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Soulat, S. Loyau, V. Baudouin, L. Maisonneuve, M.-F. Hurtaud-Roux, N. Schlegel, C. Loirat, and E. Angles-Cano Effect of Individual Plasma Lipoprotein(a) Variations In Vivo on Its Competition With Plasminogen for Fibrin and Cell Binding : An In Vitro Study Using Plasma From Children With Idiopathic Nephrotic Syndrome Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 575 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. B Feldman Assorted monounsaturated fatty acids promote healthy hearts Am. J. Clinical Nutrition, December 1, 1999; 70(6): 953 - 954. [Full Text] [PDF]
|
|
|
|
|
|
B Jorgensen, S Simonsen, K Endresen, K Forfang, T Egeland, A.T Hostmark, and E Thaulow Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids Eur. Heart J., October 1, 1999; 20(19): 1407 - 1414. [Abstract] [PDF]
|
|
|
|
|
|
C. A. Glader, B. Stegmayr, J. Boman, H. Stenlund, L. Weinehall, G. Hallmans, and G. H. Dahlen Chlamydia pneumoniae Antibodies and High Lipoprotein(a) Levels Do Not Predict Ischemic Cerebral Infarctions : Results From a Nested Case-Control Study in Northern Sweden Stroke, October 1, 1999; 30(10): 2013 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Harjai Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen Ann Intern Med, September 7, 1999; 131(5): 376 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. V. Pinkerton and R. Santen Alternatives to the Use of Estrogen in Postmenopausal Women Endocr. Rev., June 1, 1999; 20(3): 308 - 320. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. N. B. Merz The Efficacy of Hormonal Therapy for Reducing Coronary Artery Disease in Women J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1810 - 1812. [Full Text]
|
|
|
|
|
|
O. T. Raitakari, M. R. Adams, and D. S. Celermajer Effect of Lp(a) on the Early Functional and Structural Changes of Atherosclerosis Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 990 - 995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Mooser, F. Tinguely, P. Fontana, V. Lenain, M. Vaglio, P. Ruchat, L. K. von Segesser, S. M. Marcovina, M. Markert, R. Darioli, et al. Effect of Cardiopulmonary Bypass and Heparin on Plasma Levels of Lp(a) and Apo(a) Fragments Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 1060 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Querfeld, S. Döpper, A. Gradehand, P. Kiencke, F. Wahn, and H.-J. Zeisel Long-Term Treatment with Growth Hormone Has No Persisting Effect on Lipoprotein(a) in Patients with Turner's Syndrome J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 967 - 970. [Abstract] [Full Text]
|
|
|
|
|
|
E. Anglés-Cano, S. Loyau, G. Cardoso-Saldaña, R. Couderc, and P. Gillery A novel kringle-4 number-based recombinant apo[a] standard for human apo[a] phenotyping J. Lipid Res., February 1, 1999; 40(2): 354 - 359. [Abstract] [Full Text]
|
|
|
|
 |
|
 N M Al-Saady, E W Leatham, S Gupta, J T C Kwan, J B Eastwood, and C A Seymour Monocyte expression of tissue factor and adhesion molecules: the link with accelerated coronary artery disease in patients with chronic renal failure Heart, February 1, 1999; 81(2): 134 - 140. [Abstract] [Full Text]
|
|
|
|
|
|
C. Gazzaruso, A. Garzaniti, P. Buscaglia, G. Bonetti, C. Falcone, P. Fratino, G. Finardi, and D. Geroldi Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age J. Am. Coll. Cardiol., January 1, 1999; 33(1): 157 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Dangas, R. Mehran, P. C. Harpel, S. K. Sharma, S. M. Marcovina, G. Dube, J. A. Ambrose, and J. T. Fallon Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation J. Am. Coll. Cardiol., December 1, 1998; 32(7): 2035 - 2042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Ruotolo, C.-G.o. Ericsson, C. Tettamanti, F. Karpe, L. Grip, B. Svane, J. Nilsson, U. de Faire, and A. Hamsten Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1648 - 1656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Y. Craig, L. M. Neveux, G. E. Palomaki, M. M. Cleveland, and J. E. Haddow Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies Clin. Chem., November 1, 1998; 44(11): 2301 - 2306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Van schooten, A. Hirvonen, L. M. Maas, B. A. De mol, J. C. S. kleinjans, D. A. Bell, and J. D. Durrer Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue FASEB J, October 1, 1998; 12(13): 1409 - 1417. [Abstract] [Full Text]
|
|
|
|
|
|
W. Su, H. Campos, H. Judge, B. W. Walsh, and F. M. Sacks Metabolism of Apo(a) and ApoB100 of Lipoprotein(a) in Women: Effect of Postmenopausal Estrogen Replacement J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3267 - 3276. [Abstract] [Full Text]
|
|
|
|
|
|
V. Mijatovic, P. Kenemans, J. C. Netelenbos, E. R. A. Peters-Muller, G. J. van Kamp, G. A. Voetberg, P. H. M. van de Weijer, and M. J. van der Mooren Oral 17{beta}-Estradiol Continuously Combined with Dydrogesterone Lowers Serum Lipoprotein(a) Concentrations in Healthy Postmenopausal Women J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3543 - 3547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. N. Hopkins, L. L. Wu, S. C. Hunt, B. C. James, G. M. Vincent, and R. R. Williams Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2783 - 2792. [Abstract] [Full Text]
|
|
|
|
|
|
W.-K. Min, J. O. Lee, and J. W. Huh Relation between lipoprotein(a) concentrations in patients with acute-phase response and risk analysis for coronary heart disease Clin. Chem., October 1, 1997; 43(10): 1891 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. A. McCormick, J. K. Ng, C. M. Cham, S. Taylor, S. M. Marcovina, J. P. Segrest, R. E. Hammer, and S. G. Young Transgenic Mice Expressing Human ApoB95 and ApoB97. EVIDENCE THAT SEQUENCES WITHIN THE CARBOXYL-TERMINAL PORTION OF HUMAN apoB100 ARE IMPORTANT FOR THE ASSEMBLY OF LIPOPROTEIN(a) J. Biol. Chem., September 19, 1997; 272(38): 23616 - 23622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T. Nguyen, R. D. Ellefson, D. O. Hodge, K. R. Bailey, T. E. Kottke, and H. S. Abu-Lebdeh Predictive Value of Electrophoretically Detected Lipoprotein(a) for Coronary Heart Disease and Cerebrovascular Disease in a Community-Based Cohort of 9936 Men and Women Circulation, September 2, 1997; 96(5): 1390 - 1397. [Abstract] [Full Text]
|
|
|
|
|
|
B. J. Biemond, P. W. Friederich, M. L. Koschinsky, M. Levi, W. Sangrar, J. Xia, H. R. Buller, and J. W. t. Cate Apolipoprotein(a) Attenuates Endogenous Fibrinolysis in the Rabbit Jugular Vein Thrombosis Model In Vivo Circulation, September 2, 1997; 96(5): 1612 - 1615. [Abstract] [Full Text]
|
|
|
|
|
|
B. A. Clevidence, J. T. Judd, E. J. Schaefer, J. L. Jenner, A. H. Lichtenstein, R. A. Muesing, J. Wittes, and M. E. Sunkin Plasma Lipoprotein (a) Levels in Men and Women Consuming Diets Enriched in Saturated, Cis-, or Trans-Monounsaturated Fatty Acids Arterioscler Thromb Vasc Biol, September 1, 1997; 17(9): 1657 - 1661. [Abstract] [Full Text]
|
|
|
|
|
|
C. H. Tuck, S. Holleran, and L. Berglund Hormonal Regulation of Lipoprotein(a) Levels: Effects of Estrogen Replacement Therapy on Lipoprotein(a) and Acute Phase Reactants in Postmenopausal Women Arterioscler Thromb Vasc Biol, September 1, 1997; 17(9): 1822 - 1829. [Abstract] [Full Text]
|
|
|
|
|
|
G. M. Darling, J. A. Johns, P. I. McCloud, and S. R. Davis Estrogen and Progestin Compared with Simvastatin for Hypercholesterolemia in Postmenopausal Women N. Engl. J. Med., August 28, 1997; 337(9): 595 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Stein and R. S. Rosenson Lipoprotein Lp(a) Excess and Coronary Heart Disease Arch Intern Med, June 9, 1997; 157(11): 1170 - 1176. [Abstract] [PDF]
|
|
|
|
|
|
L. A. Sechi, F. Kronenberg, S. De Carli, E. Falleti, L. Zingaro, C. Catena, G. Utermann, and E. Bartoli Association of Serum Lipoprotein(a) Levels and Apolipoprotein(a) Size Polymorphism With Target-Organ Damage in Arterial Hypertension JAMA, June 4, 1997; 277(21): 1689 - 1695. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Yano, K. Shimokawa, Y. Okada, and A. Noma Immunolocalization of Lipoprotein(a) in Wounded Tissues J. Histochem. Cytochem., April 1, 1997; 45(4): 559 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Catalano, E. Perilli, G. Carzaniga, G. Scandale, and M. Carotta Arterial Damage, Triglycerides, Apolipoprotein, and Lp-(a) Values in PVD Patients Clinical and Applied Thrombosis/Hemostasis, April 1, 1997; 3(2): 104 - 109. [Abstract] [PDF]
|
|
|
|
|
|
K. Orth-Gomer, M. A. Mittleman, K. Schenck-Gustafsson, S. P. Wamala, M. Eriksson, K. Belkic, R. Kirkeeide, B. Svane, and L. Ryden Lipoprotein(a) as a Determinant of Coronary Heart Disease in Young Women Circulation, January 21, 1997; 95(2): 329 - 334. [Abstract] [Full Text]
|
|
|
|
|
|
E. A.L. Biessen, H. Vietsch, and T. J.C. van Berkel Induction of Hepatic Uptake of Lipoprotein(a) by Cholesterol-Derivatized Cluster Galactosides Arterioscler Thromb Vasc Biol, December 1, 1996; 16(12): 1552 - 1558. [Abstract] [Full Text]
|
|
|
|
|
|
B. R. Gabel, L. F. May, S. M. Marcovina, and M. L. Koschinsky Lipoprotein(a) Assembly: Quantitative Assessment of the Role of Apo(a) Kringle IV Types 2-10 in Particle Formation Arterioscler Thromb Vasc Biol, December 1, 1996; 16(12): 1559 - 1567. [Abstract] [Full Text]
|
|
|
|
|
|
S. Sunayama, H. Daida, H. Mokuno, H. Miyano, H. Yokoi, Y. J. Lee, H. Sakurai, and H. Yamaguchi Lack of Increased Coronary Atherosclerotic Risk Due to Elevated Lipoprotein(a) in Women >=55 Years of Age Circulation, September 15, 1996; 94(6): 1263 - 1268. [Abstract] [Full Text]
|
|
|
|
|
|
C. J. Kim, Y. K. Min, W. S. Ryu, J. W. Kwak, and U. H. Ryoo Effect of Hormone Replacement Therapy on Lipoprotein(a) and Lipid Levels in Postmenopausal Women: Influence of Various Progestogens and Duration of Therapy Arch Intern Med, August 12, 1996; 156(15): 1693 - 1700. [Abstract] [PDF]
|
|
|
|
|
|
D. Baldassarre, E. Tremoli, G. Franceschini, S. Michelagnoli, and C.R. Sirtori Plasma Lipoprotein(a) Is an Independent Factor Associated With Carotid Wall Thickening in Severely but Not Moderately Hypercholesterolemic Patients Stroke, June 1, 1996; 27(6): 1044 - 1049. [Abstract] [Full Text]
|
|
|
|
|
|
C. Haines, T. Chung, A. Chang, J. Masarei, B. Tomlinson, and E. Wong Effect of Oral Estradiol on Lp(a) and Other Lipoproteins in Postmenopausal Women: A Randomized, Double-blind, Placebo-Controlled, Crossover Study Arch Intern Med, April 22, 1996; 156(8): 866 - 872. [Abstract] [PDF]
|
|
|
|
|
|
C. J. Kim, W. S. Ryu, J. W. Kwak, C. T. Park, and U. H. Ryoo Changes in Lp(a) Lipoprotein and Lipid Levels After Cessation of Female Sex Hormone Production and Estrogen Replacement Therapy Arch Intern Med, March 11, 1996; 156(5): 500 - 504. [Abstract] [PDF]
|
|
|
|
|
|
P. J. Schreiner, G. Heiss, H.A. Tyroler, J. D. Morrisett, C.E. Davis, and R. Smith Race and Gender Differences in the Association of Lp(a) With Carotid Artery Wall Thickness : The Atherosclerosis Risk in Communities (ARIC) Study Arterioscler Thromb Vasc Biol, March 1, 1996; 16(3): 471 - 478. [Abstract] [Full Text]
|
|
|
|
|
|
M. Margaglione, G. DiMinno, E. Grandone, E. Celentano, G. Vecchione, G. Cappucci, M. Grilli, F. P. Mancini, A. Postiglione, S. Panico, et al. Plasma Lipoprotein(a) Levels in Subjects Attending a Metabolic Ward : Discrimination Between Individuals With and Without a History of IschemicStroke Arterioscler Thromb Vasc Biol, January 1, 1996; 16(1): 120 - 128. [Abstract] [Full Text]
|
|
|
|
|
|
R. Carmena, S. Lussier-Cacan, M. Roy, A. Minnich, A. Lingenhel, F. Kronenberg, and J. Davignon Lp(a) Levels and Atherosclerotic Vascular Disease in a Sample of Patients With Familial Hypercholesterolemia Sharing the Same Gene Defect Arterioscler Thromb Vasc Biol, January 1, 1996; 16(1): 129 - 136. [Abstract] [Full Text]
|
|
|
|
|
|
M. Averna, S. M. Marcovina, D. Noto, T. G. Cole, E. S. Krul, and G. Schonfeld Familial Hypobetalipoproteinemia Is Not Associated With Low Levels of Lipoprotein(a) Arterioscler Thromb Vasc Biol, December 1, 1995; 15(12): 2165 - 2175. [Abstract] [Full Text]
|
|
|
|
|
|
G. Jurgens, W. C. Taddei-Peters, P. Koltringer, W. Petek, Q. Chen, J. Greilberger, P. F. Macomber, B. T. Butman, A. G. Stead, and J. H. Ransom Lipoprotein(a) Serum Concentration and Apolipoprotein(a) Phenotype Correlate With Severity and Presence of Ischemic Cerebrovascular Disease Stroke, October 1, 1995; 26(10): 1841 - 1848. [Abstract] [Full Text]
|
|
|
|
|
|
J. Willeit, S. Kiechl, P. Santer, F. Oberhollenzer, G. Egger, E. Jarosch, and A. Mair Lipoprotein(a) and Asymptomatic Carotid Artery Disease : Evidence of a Prominent Role in the Evolution of Advanced Carotid Plaques: The Bruneck Study Stroke, September 1, 1995; 26(9): 1582 - 1587. [Abstract] [Full Text]
|
|
|
|
|
|
S. L. Tokgozoglu, F. Ozmen, M. Kabukcu, A. Karanfil, K. Aytemir, C. Ozkuyumcu, and S. Ugurlu Does Increased Lipoprotein (a) Impair the Effectiveness of Thrombolysis With Streptokinase? Angiology, August 1, 1995; 46(8): 727 - 731. [Abstract] [PDF]
|
|
|
|
|
|
I. Bolibar, S. G. Thompson, A. von Eckardstein, M. Sandkamp, and G. Assmann Dose-Response Relationships of Serum Lipid Measurements With the Extent of Coronary Stenosis : Strong, Independent, and Comprehensive Arterioscler Thromb Vasc Biol, August 1, 1995; 15(8): 1035 - 1042. [Abstract] [Full Text]
|
|
|
|
|
|
D. J. Moliterno, E. V. Jokinen, A. R. Miserez, R. A. Lange, J. E. Willard, E. Boerwinkle, L. D. Hillis, and H. H. Hobbs No Association Between Plasma Lipoprotein(a) Concentrations and the Presence or Absence of Coronary Atherosclerosis in African-Americans Arterioscler Thromb Vasc Biol, July 1, 1995; 15(7): 850 - 855. [Abstract] [Full Text]
|
|
|
|
|
|
V. N. Trieu and W. J. McConathy A Two-step Model for Lipoprotein(a) Formation J. Biol. Chem., June 30, 1995; 270(26): 15471 - 15474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Ridker, M. J. Stampfer, and C. H. Hennekens Plasma Concentration of Lipoprotein(a) and the Risk of Future Stroke JAMA, April 26, 1995; 273(16): 1269 - 1273. [Abstract] [PDF]
|
|
|
|
|
|
G. N. Levine, J. F. Keaney, and J. A. Vita Cholesterol Reduction in Cardiovascular Disease -- Clinical Benefits and Possible Mechanisms N. Engl. J. Med., February 23, 1995; 332(8): 512 - 521. [Full Text] [PDF]
|
|
|
|
|
|
F. M. Sacks, R. McPherson, and B. W. Walsh Effect of Postmenopausal Estrogen Replacement on Plasma Lp(a) Lipoprotein Concentrations Arch Intern Med, May 23, 1994; 154(10): 1106 - 1110. [Abstract] [PDF]
|
|
|
|
|
|
R. J. Valentine, P. A. Grayburn, G. L. Vega, and S. M. Grundy Lp(a) Lipoprotein Is an Independent, Discriminating Risk Factor for Premature Peripheral Atherosclerosis Among White Men Arch Intern Med, April 11, 1994; 154(7): 801 - 806. [Abstract] [PDF]
|
|
|
|
|
|
E. J. Schaefer, S. Lamon-Fava, J. L. Jenner, J. R. McNamara, J. M. Ordovas, C. E. Davis, J. M. Abolafia, K. Lippel, and R. I. Levy Lipoprotein(a) Levels and Risk of Coronary Heart Disease in Men: The Lipid Research Clinics Coronary Primary Prevention Trial JAMA, April 6, 1994; 271(13): 999 - 1003. [Abstract] [PDF]
|
|
|
|
|
|
V. Gurewich and M. Mittleman Lipoprotein(a) in Coronary Heart Disease: Is It a Risk Factor After All? JAMA, April 6, 1994; 271(13): 1025 - 1026. [Abstract] [PDF]
|
|
|
|
|
|
P. M. Ridker, C. H. Hennekens, and M. J. Stampfer A Prospective Study of Lipoprotein(a) and the Risk of Myocardial Infarction JAMA, November 10, 1993; 270(18): 2195 - 2199. [Abstract] [PDF]
|
|
|
|
|
|
M. R. Soma, I. Osnago-Gadda, R. Paoletti, R. Fumagalli, J. D. Morrisett, M. Meschia, and P. Crosignani The Lowering of Lipoprotein[a] Induced by Estrogen Plus Progesterone Replacement Therapy in Postmenopausal Women Arch Intern Med, June 28, 1993; 153(12): 1462 - 1468. [Abstract] [PDF]
|
|
|
|
|
|
D. J. Rader and H. B. Brewer Jr Lipoprotein(a) Clinical Approach to a Unique Atherogenic Lipoprotein JAMA, February 26, 1992; 267(8): 1109 - 1112. [Abstract] [PDF]
|
|
|
|
 |
|
 R. J. Valentine Lipoprotein(a): A New Risk Factor for Vascular Disease Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1992; 5(2): 84 - 99. [PDF]
|
|
|
|
|
|
A. M. Scanu, R. M. Lawn, and K. Berg Lipoprotein(a) and Atherosclerosis Ann Intern Med, August 1, 1991; 115(3): 209 - 218. [Abstract] [PDF]
|
|
|
|
|
|
E. Barrett-Connor and T. L. Bush Estrogen and Coronary Heart Disease in Women JAMA, April 10, 1991; 265(14): 1861 - 1867. [Abstract] [PDF]
|
|
|
|
|
|
B. G. Jacob, W. O. Richter, and P. Schwandt Lovastatin, Pravastatin, and Serum Lipoprotein(a) Ann Intern Med, May 1, 1990; 112(9): 713 - 714. [Abstract] [PDF]
|
|
|
|
|
|
E. Bruckert, P. Davidoff, A. Grimaldi, J. Truffert, P. Giral, R. Doumith, F. Thervet, and J. L. De Gennes Increased Serum Levels of Lipoprotein(a) in Diabetes Mellitus and Their Reduction With Glycemic Control JAMA, January 5, 1990; 263(1): 35 - 36. [Abstract] [PDF]
|
|
|
|
 |
|
 G Utermann The mysteries of lipoprotein(a) Science, November 17, 1989; 246(4932): 904 - 910. [Abstract] [PDF]
|
|